caprylates has been researched along with fluconazole in 1 studies
Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (fluconazole) | Trials (fluconazole) | Recent Studies (post-2010) (fluconazole) |
---|---|---|---|---|---|
5,061 | 100 | 2,339 | 9,343 | 721 | 3,664 |
Protein | Taxonomy | caprylates (IC50) | fluconazole (IC50) |
---|---|---|---|
Lanosterol 14-alpha demethylase | Candida albicans SC5314 | 0.1296 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 9.21 | |
Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | 0.88 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borowicz, SM; Clemes Külkamp-Guerreiro, I; da Rosa Monte Machado, G; Domingues Bianchin, M; Meneghello Fuentefria, A; Pippi, B; Raffin Pohlmann, A; Stanisçuaski Guterres, S | 1 |
1 other study(ies) available for caprylates and fluconazole
Article | Year |
---|---|
Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caprylates; Delayed-Action Preparations; Drug Compounding; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Genes, MDR; Hexoses; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nanoparticles; Palmitates; Particle Size; Triglycerides; Verapamil | 2019 |